These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 8548339)
1. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene. Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339 [TBL] [Abstract][Full Text] [Related]
2. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line. Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581 [TBL] [Abstract][Full Text] [Related]
3. Alteration of thymidine kinase activity in cells treated with an antiviral agent. Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632 [TBL] [Abstract][Full Text] [Related]
4. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells. Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716 [TBL] [Abstract][Full Text] [Related]
5. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. Avramis VI; Kwock R; Solorzano MM; Gomperts E J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464 [TBL] [Abstract][Full Text] [Related]
6. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene. Gröschel B; Höver G; Doerr HW; Cinatl J Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):487-92. PubMed ID: 11563064 [TBL] [Abstract][Full Text] [Related]
7. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine. Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922 [TBL] [Abstract][Full Text] [Related]
8. Further study of the mechanism underlying the cellular resistance to AZT. Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger. Meng Q; Su T; O'Neill JP; Walker VE Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380 [TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. Antonelli G; Turriziani O; Verri A; Narciso P; Ferri F; D'Offizi G; Dianzani F AIDS Res Hum Retroviruses; 1996 Feb; 12(3):223-8. PubMed ID: 8835200 [TBL] [Abstract][Full Text] [Related]
11. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision. Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT). Periclou AP; Nandy P; Avramis VI In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870 [TBL] [Abstract][Full Text] [Related]
13. Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine. Cases-González CE; Franco S; Martínez MA; Menéndez-Arias L J Mol Biol; 2007 Jan; 365(2):298-309. PubMed ID: 17070543 [TBL] [Abstract][Full Text] [Related]
14. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine. Guettari N; Loubière L; Brisson E; Klatzmann D Virology; 1997 Sep; 235(2):398-405. PubMed ID: 9281520 [TBL] [Abstract][Full Text] [Related]
15. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV). Degrève B; De Clercq E; Balzarini J Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592 [TBL] [Abstract][Full Text] [Related]
16. Biochemical and genetical analysis of AZT-resistant HIV-mutants. Biesert L; Zimmermann F; Schröder B; Matthes E; Suhartono H; Dietrich U; Rübsamen-Waigmann H Behring Inst Mitt; 1991 Jul; (89):74-80. PubMed ID: 1930105 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1. Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine. Savaraj N; Wu C; Wangpaichitr M; Kuo MT; Lampidis T; Robles C; Furst AJ; Feun L Int J Oncol; 2003 Jul; 23(1):173-9. PubMed ID: 12792791 [TBL] [Abstract][Full Text] [Related]
19. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance. Kerr SG; Anderson KS Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation and cytotoxicity of therapeutic nucleoside analogues: a comparison of alpha and gamma herpesvirus thymidine kinase suicide genes. Cazaux C; Tiraby M; Loubiere L; Haren L; Klatzmann D; Tiraby G Cancer Gene Ther; 1998; 5(2):83-91. PubMed ID: 9570299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]